GAMCO Investors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,144
Closed -$230K 1060
2025
Q3
$230K Sell
4,144
-400
-9% -$23.4K ﹤0.01% 965
2025
Q2
$314K Buy
+4,544
New +$309K ﹤0.01% 927
2023
Q2
Sell
-2,968
Closed -$236K 888
2023
Q1
$236K Hold
2,968
﹤0.01% 812
2022
Q4
$201K Buy
+2,968
New +$174K ﹤0.01% 832
2016
Q3
Sell
-12,352
Closed -$332K 817
2016
Q2
$332K Sell
12,352
-98
-0.8% -$2.69K ﹤0.01% 724
2016
Q1
$337K Buy
12,450
+30
+0.2% +$804 ﹤0.01% 717
2015
Q4
$361K Buy
12,420
+80
+0.6% +$2.21K ﹤0.01% 710
2015
Q3
$335K Sell
12,340
-750
-6% -$21.2K ﹤0.01% 734
2015
Q2
$358K Sell
13,090
-310
-2% -$8.71K ﹤0.01% 735
2015
Q1
$358K Sell
13,400
-40
-0.3% -$921 ﹤0.01% 744
2014
Q4
$284K Hold
13,440
﹤0.01% 784
2014
Q3
$320K Sell
13,440
-1,800
-12% -$41.4K ﹤0.01% 787
2014
Q2
$352K Sell
15,240
-90
-0.6% -$1.99K ﹤0.01% 771
2014
Q1
$350K Sell
15,330
-1,710
-10% -$36.4K ﹤0.01% 752
2013
Q4
$315K Hold
17,040
﹤0.01% 748
2013
Q3
$288K Sell
17,040
-100
-0.6% -$1.68K ﹤0.01% 749
2013
Q2
$266K Buy
+17,140
New +$285K ﹤0.01% 739

Other funds holding NVO

GAMCO Investors's NVO Position: Q4 2025 in Review

GAMCO Investors sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 4,144 shares — an estimated $230K sold.

GAMCO Investors first reported a position in NVO in Q2 2013 and held it in 17 quarters. The position peaked at $361K in Q4 2015. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • GAMCO Investors reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • GAMCO Investors sold 4,144 Novo Nordisk shares in Q4 2025, an estimated $230K.
  • GAMCO Investors first reported a position in Novo Nordisk in Q2 2013 and held it in 17 quarters.
  • GAMCO Investors's Novo Nordisk position peaked at $361K in Q4 2015.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on GAMCO Investors's 13F filing for Q4 2025, filed 5 Feb 2026.